http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2473773

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article
endingPage 564
issn 0049-3848
issueIdentifier 5
pageRange 558-564
publicationName Thrombosis Research
startingPage 558
bibliographicCitation Nishio R, Shinke T, Otake H, Nakagawa M, Inoue T, Hariki H, Osue T, Taniguchi Y, Iwasaki M, Hiranuma N, Konishi A, Kinutani H, Kuroda M, Hirata K. Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers. Thromb Res. 2013 Nov;132(5):558–64. doi: 10.1016/j.thromres.2013.09.008. PMID: 24080149.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7517d64ffd63597f0fd9947d9a48c262
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12a0922ae3a8f159a2f9897235413c3a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5838608466143f788b8eab8f683a3f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d8b37334b5fa5dbc6d9e63eb63056bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3661ec56fdcd0bc2306b9500ea3f9a86
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ae19e0ab2f2860f3456c8dc95961bfc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1bd97c6c45c526aa05b8f858facf749
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09ad2456a8b2d22818293aba22972396
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65cb505a06d8845523252c8c2306525e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7eda41e22677e3d3c044a150d9f63c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a86d947180160c834ccbd834734959f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f7d8a301a070695e3289740b68cc04f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c522e2fc12b332d47aa85386a012116d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ffe359cae385bd35bbfb2872b02c851
date 201311
identifier https://doi.org/10.1016/j.thromres.2013.09.008
https://pubmed.ncbi.nlm.nih.gov/24080149
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7735
https://portal.issn.org/resource/ISSN/0049-3848
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers
discusses http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0080022
http://id.nlm.nih.gov/mesh/M0590604
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0132976
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0001774
http://id.nlm.nih.gov/mesh/M0001864
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D013927Q000188
http://id.nlm.nih.gov/mesh/D001189Q000235
http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D043303Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D065731
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D013927Q000201
http://id.nlm.nih.gov/mesh/D013927Q000235
http://id.nlm.nih.gov/mesh/D011110
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D054855Q000009
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D013927Q000209
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe2bd2858a81c47d2cc867a44fa255c3
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b360533648df9c14281910a5ec4e45f0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1557
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5444

Total number of triples: 66.